Form 4: Neogen CEO John Edward Adent Reports Stock Transactions
SEC Form 4 Filing
Neogen CEO John Edward Adent reports the vesting and settlement of restricted stock units (RSUs) into common stock, along with a disposition of shares to cover tax obligations.
Summary
- On October 14, 2024, Neogen CEO John Edward Adent reported transactions involving the company's stock.
- Specifically, 3,064 restricted stock units (RSUs) vested and were settled for an equal number of shares of common stock at a price of $14.43.
- Additionally, 892 shares were disposed of to cover tax obligations related to the RSU vesting, also at $14.43.
- Following these transactions, Adent directly owns 218,649 shares of Neogen common stock and 6,127 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine filing related to executive compensation and does not indicate any significant positive or negative sentiment.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are often related to compensation packages. The vesting of RSUs is a typical form of equity compensation.
Key Dates
| Date | Description |
|---|---|
| 10/14/2024 | Date of RSU vesting and stock transactions |
| 10/15/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.